Quantifying RNA Encapsulation in LNPs Using the Modified RiboGreen Assay

Added:

Limitations of Dye-Exclusion and the Shift to Separation-Based Quantification

While the modified RiboGreen assay is the industry standard for determining RNA encapsulation efficiency due to its simplicity, it possesses critical limitations. The primary criticism lies in its reliance on detergent-mediated lysis (typically using Triton X-100). Incomplete LNP disruption can lead to underestimated total RNA concentration and artificially inflated encapsulation efficiency measurements. Furthermore, the assay only measures accessible nucleic acids; it cannot distinguish between fully intact functional RNA and degraded fragments inside the nanoparticle. Consequently, critics champion separation-based analytical techniques such as Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC), capillary gel electrophoresis (CGE), and asymmetric flow field-flow fractionation (AF4). These methods physically separate free RNA, encapsulated RNA, and degraded species prior to quantification. This yields highly accurate encapsulation metrics unaffected by detergent-dye interference, while simultaneously providing vital data on RNA integrity and stability, representing a more rigorous standard for LNP characterization.

Fundamental structure and components of Lipid Nanoparticles (LNPs), including ionizable lipids, helper lipids, cholesterol, and PEGylated lipids.
Basic principles of fluorescence spectroscopy, specifically how fluorophores interact with nucleic acids to emit light.
The chemistry of RNA, including its stability, vulnerability to RNases, and structural differences compared to DNA.
Principles of quantitative analysis, including preparing standard curves, serial dilutions, and using spectrophotometers or microplate readers.
The role of detergents (such as Triton X-100) in disrupting lipid bilayers to release encapsulated cargo.
Complementary LNP characterization techniques, such as Dynamic Light Scattering (DLS) for particle sizing and Zeta Potential for surface charge determination.
In vitro and in vivo transfection assays to correlate RNA encapsulation efficiency with functional gene expression or knockdown.
LNP stability testing protocols, exploring how encapsulation efficiency changes over time under various storage temperatures and pH conditions.
Quality Control (QC) and regulatory standards (such as GMP) required for scaling up LNP-RNA formulations for clinical use.
Advanced formulation engineering, such as modifying lipid ratios or incorporating targeting ligands, and evaluating their impact on encapsulation and release kinetics.
13.3K views110likes42:19@PrecisionNanoSystemsOriginal Release: 2020-06-27

The modified Ribogreen assay quantifies RNA encapsulation efficiency in lipid nanoparticles by measuring the difference between total RNA (measured after lysing particles with Triton X-100) and unencapsulated RNA (measured without lysis), using a fluorescent dye that specifically binds to RNA; the assay involves preparing 1x TE buffer, diluting RNA samples to fall within the standard curve range (0.12-2.5 μg/μL), plating samples in a 96-well plate with Triton-treated and non-Triton-treated wells, adding Ribogreen reagent diluted 1:100, and calculating encapsulation efficiency using Excel with blank subtraction and standard curve analysis.